Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-28 Sale |
2021-02-01 4:30 pm |
Inozyme Pharma Inc. | INZY | Novo Holdings A/S 10% Owner |
375,000 | $21 | $7,875,000 | 2,194,379 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-23 Option Award |
2021-06-24 4:10 pm |
N/A 2031-06-22 |
Inozyme Pharma Inc. | INZY | Inozyme Pharma Inc. Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-18 4:18 pm |
N/A 2031-05-16 |
Inozyme Pharma Inc. | INZY | DiPalma Stephen J. Interim CFO |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-25 4:05 pm |
N/A 2031-03-23 |
Inozyme Pharma Inc. | INZY | Basso Stephen SVP Finance (PFO) |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-17 5:57 pm |
N/A 2031-03-03 |
Inozyme Pharma Inc. | INZY | Jungles Steven J SVP, CTO |
42,000 | $0 | 42,000 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-17 5:56 pm |
N/A 2031-03-03 |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
117,000 | $0 | 117,000 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-17 5:56 pm |
N/A 2031-03-03 |
Inozyme Pharma Inc. | INZY | Bjarke Henric Bjorn SVP, COO |
51,000 | $0 | 51,000 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-17 5:56 pm |
N/A 2031-03-03 |
Inozyme Pharma Inc. | INZY | Basso Stephen SVP Finance (PFO) |
27,000 | $0 | 27,000 (Direct) |
View |
| 2021-02-02 Option Award |
2021-02-04 5:11 pm |
N/A 2031-02-01 |
Inozyme Pharma Inc. | INZY | Wenkert Deborah SVP, CMO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-01-13 Option Award |
2021-01-14 4:19 pm |
N/A 2030-04-22 |
Inozyme Pharma Inc. | INZY | Jungles Steven J SVP, CTO |
44,315 | $0 | 44,315 (Direct) |
View |
| 2021-01-13 Option Award |
2021-01-14 4:17 pm |
N/A 2030-04-22 |
Inozyme Pharma Inc. | INZY | Huertas Pedro SVP, CMO |
36,074 | $0 | 36,074 (Direct) |
View |
| 2021-01-13 Option Award |
2021-01-14 4:16 pm |
N/A 2030-04-22 |
Inozyme Pharma Inc. | INZY | Bjarke Henric Bjorn SVP, COO |
51,105 | $0 | 51,105 (Direct) |
View |
| 2021-01-13 Option Award |
2021-01-14 4:15 pm |
N/A 2030-04-22 |
Inozyme Pharma Inc. | INZY | Basso Stephen SVP Finance (PFO) |
41,794 | $0 | 41,794 (Direct) |
View |
| 2021-01-13 Option Award |
2021-01-14 4:14 pm |
N/A 2030-04-22 |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
225,975 | $0 | 225,975 (Direct) |
View |